University of Tokyo-born AI Startup IDATENase Inc. Certified as a 'Matsuo Lab Certified Startup®︎'
Key facts
- University of Tokyo-born AI Startup IDATENase Inc. Certified as a 'Matsuo Lab Certified Startup®︎'
- IDATENase Inc., an AI startup from the University of Tokyo, has been certified as a 'Matsuo Lab Certified Startup®︎.' With a mission of 'AI for Science, Science for AI,' the company provides AI solutions for scientific and technological R&D in fields like cosmetics, pharmaceuticals, and energy, aiming to accelerate R&D and lead global discoveries.
- Source: PR Times
- Date: April 30, 2026
Direct answer
IDATENase Inc., an AI startup from the University of Tokyo, has been certified as a 'Matsuo Lab Certified Startup®︎.' With a mission of 'AI for Science, Science for AI,' the company provides AI solutions for scientific and technological R&D in fields like cosmetics, pharmaceuticals, and energy, aiming to accelerate R&D and lead global discoveries.
- Citation
- University of Tokyo-born AI Startup IDATENase Inc. Certified as a 'Matsuo Lab Certified Startup®︎' (April 30, 2026), PR Times
- Source
- PR Times
- Date
- April 30, 2026
IDATENase Inc., an AI startup from the University of Tokyo, has been certified as a 'Matsuo Lab Certified Startup®︎.' With a mission of 'AI for Science, Science for AI,' the company provides AI solutions for scientific and technological R&D in fields like cosmetics, pharmaceuticals, and energy, aiming to accelerate R&D and lead global discoveries.
📋 Article Processing Timeline
- 📰 Published: April 30, 2026 at 19:00
- 🔍 Collected: April 30, 2026 at 10:31
- 🤖 AI Analyzed: April 30, 2026 at 19:46 (9h 14m after Collected)
About "Matsuo Lab Certified Startup®︎"
"Matsuo Lab Certified Startup®︎" refers to a selected group of startup companies founded by Matsuo Lab alumni or established with support from Matsuo Lab, recognized for their growth potential in both technology and business, and committed to expanding the ecosystem in resonance with Matsuo Lab's philosophy. (Registered Trademarks No. 6667237, No. 6710069)
Matsuo Lab will continue its efforts to return cutting-edge technology to society and realize a new industry-academia ecosystem through the nurturing of startup companies.
About IDATENase Inc.
IDATENase, an AI startup originating from the University of Tokyo, provides advanced AI technology solutions for complex research and development challenges rooted in scientific fields such as cosmetics, pharmaceuticals, regenerative medicine, medicine, chemistry, and energy. Under the mission "AI for Science, Science for AI," IDATENase addresses scientific and complex problems with sophisticated AI technology, including optimization of iPS cell culture conditions, formulation design and ingredient blending optimization, virtual staining and image analysis, molecular design and candidate compound discovery, and material search and process condition optimization. Going beyond mere operational efficiency or supporting Proof-of-Concepts (PoCs), the company aims to structure the research process itself, accelerate R&D, and ultimately become a standard infrastructure supporting research and development and scientific technology, leading global discoveries.
Comment from Shunsuke Fukuda, Representative Director CEO:
"We are deeply honored to be certified as a Matsuo Lab Certified Startup at this time.
In recent years, the trend of enhancing research and development through AI, symbolized by the term 'AI for Science,' has significantly expanded. However, we perceive this trend not as a transient keyword, but as a profound transformation where the very activities of scientific technology — experimentation, analysis, design, and evaluation — are supported by data and models.
The AI required in research and development settings is not merely one that returns superficially natural answers. It is crucial to understand why a hypothesis was derived, what data and knowledge it is based on, whether it can be reproduced in experiments, and if it can be scientifically explained.
IDATENase is committed to the social implementation of AI solutions that support scientific decision-making across a wide range of scientific and technological domains, including cosmetics, pharmaceuticals, regenerative medicine, medicine, chemistry, and energy. We connect the specialized knowledge of researchers and engineers with AI, and integrate experimental data, image data, spectral data, literature information, and simulation results.
Our goal is not simply operational efficiency or trendy AI application, but to achieve AI that is continuously used in the field, supporting hypothesis generation, experimental design, condition optimization, analysis, evaluation, manufacturing process improvement, and quality control, all based on scientific and technical evidence.
Moving forward, we will continue to refine our AI technology deeply rooted in scientific and technological fields, contributing to the enhancement of industrial competitiveness and the acceleration of social implementation."
■ Company Overview
IDATENase Inc.
Representative Director CEO: Shunsuke Fukuda
Location: 6-25-14 Hongo, Bunkyo-ku, Tokyo
HP: https://idatenase.com
Contact for this matter:
(Contact: Chikato Shoji, Mail: shoji-chikato[at]idatenase.com)
FAQ
What are the key facts in this article?
IDATENase Inc., an AI startup from the University of Tokyo, has been certified as a 'Matsuo Lab Certified Startup®︎.' With a mission of 'AI for Science, Science for AI,' the company provides AI solutions for scientific and technological R&D in fields like cosmetics, pharmaceuticals, and energy, aiming to accelerate R&D and lead global discoveries.
What is the direct answer?
IDATENase Inc., an AI startup from the University of Tokyo, has been certified as a 'Matsuo Lab Certified Startup®︎.' With a mission of 'AI for Science, Science for AI,' the company provides AI solutions for scientific and technological R&D in fields like cosmetics, pharmaceuticals, and energy, aiming to accelerate R&D and lead global discoveries.
What is the source and date?
PR Times: https://prtimes.jp/main/html/rd/p/000000006.000163312.html | April 30, 2026